MedTrace Logo

Pain Phenotyping of Patients With Bone Cancer Pain

NCT03908853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-03-02

No results posted yet for this study

Summary

The study aims to describe and quantify pain related to metastatic bone disease. The study will include 50 subjects with disseminated breast cancer and 20 healthy subjects. The pain will be described and quantified through (1) pain specific questionnaires, (2) quantitative sensory testing that assess sensory changes to cold, heat and mechanical stimulation of the skin overlying the metastatic site, and (3) conditioned pain modulation that investigates impairment of the endogenous inhibitory pain pathway in humans.

Conditions

Sponsors & Collaborators

  • The Novo Nordic Foundation

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Anne-Marie Heegaard, PhD · University of Copenhagen

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-05
Primary Completion
2022-02-01
Completion
2023-02-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908853 on ClinicalTrials.gov